Skip to main content
2021 Guide to Patient Support Services

2021 Oncology Guide to Patient Support Services

Boehringer Ingelheim’s Gilotrif Patient Services includes a range of programs and services offered through the company’s Solutions Plus program. This program provides support, education, and reimbursement services to patients who are prescribed Gilotrif (afatinib), as well as to their providers. Read More ›

Karyopharm Therapeutics offers comprehensive patient support services through its KaryForward program to facilitate access to Karyopharm’s oncology medication, Xpovio (selinexor), including reimbursement support and patient financial assistance. Read More ›

Puma Biotechnology, through its Puma Patient Lynx, provides a complete support services package for patients who have been prescribed Nerlynx (neratinib), to facilitate easy access and affordability. Read More ›

Pharmacyclics, an AbbVie Company, together with Janssen Biotech, created a unique set of patient support programs called YOU&i Support Program. This personalized program helps patients to access Imbruvica (ibrutinib), a Bruton kinase inhibitor; find affordability support options; and sign up for information and resources to support them during their treatment. Read More ›

Pfizer Oncology Together is a personalized support program offering patients access to Pfizer Oncology medications. This program helps with the reimbursement process and helps to identify financial assistance for patients who are prescribed Pfizer Oncology medications. Pfizer Oncology Together will connect patients with financial assistance resources, regardless of their insurance coverage. Read More ›

Novartis Oncology provides a full range of patient assistance programs and support services through Novartis Patient Assistance Now Oncology (PANO). This comprehensive support program provides support and resources for patients and providers through the Novartis Oncology Universal Co-pay Program, Novartis Patient Assistance Foundation. Read More ›

MorphoSys, through its My MISSION Support program, provides comprehensive access and support to assist patients who are prescribed Monjuvi (tafasitamab-cxix). Read More ›

Merck Helps offers a full suite of support services, including the Merck Access Program and the Merck Patient Assistance Program, to facilitate access to Merck’s drugs for eligible patients who are unable to afford their Merck medications, regardless of their insurance status. Read More ›

Eli Lilly and Company, through Lilly Oncology, offers financial assistance to qualified patients who are prescribed oncology medications and who need help in paying for their cancer medications. Read More ›

Jazz Pharmaceuticals, through its JazzCares Program, offers patients support for its hematology/oncology drugs—Defitelio (defibrotide sodium), Erwinaze (asparaginase Erwinia chrysanthemi), Vyxeos (daunorubicin and cytarabine) liposome, and Zepzelca (lurbinectedin). Read More ›

Janssen Biotech, through Janssen CarePath, offers 1 source for patient support services, focused on access, affordability, and treatment support for patients who are prescribed a Janssen Biotech oncology medication. Read More ›

IncyteCARES (Connecting to Access, Reimbursement, Education, and Support) provides a single point of contact through a registered nurse to assist eligible patients and healthcare providers in obtaining access to its oncology drugs Jakafi (ruxolitinib) tablets or Pemazyre (pemigatinib) tablets, and to connect them with continuing support and resources. Read More ›

Eisai Reimbursement Resources is a program designed to offer drug-specific assistance related to the coding, coverage, and reimbursement of select Eisai drugs, as well as a variety of patient assistance services for patients who are prescribed Eisai’s drugs and who are having difficulty paying for the cost of their care. Read More ›

EMD Serono and Pfizer provide the CoverOne support services, a set of patient assistance programs that offer reimbursement services, copay assistance, and billing and coding resources for patients who are prescribed Bavencio (avelumab), a fully human PD-L1 monoclonal antibody. Read More ›

Epizyme provides a comprehensive set of support services through its EpizymeNOW Patient Support Program, which includes several financial and patient support services to facilitate access to its oncology drug Tazverik (tazemetostat) tablets. Read More ›

Page 2 of 4